Halozyme Therapeutics, Inc. (BIT:1HALO)
Italy
· Delayed Price · Currency is EUR 46.34
0.00 (0.00%)
At close: Jun 20, 2025, 5:30 PM CET
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of €5.69 billion as of June 27, 2025. Its market cap has increased by 7.96% in one year.
Market Cap
5.69B
Enterprise Value
6.37B
Revenue
1.00B
Ranking
n/a
PE Ratio
12.66
Stock Price
€46.34
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 5.69B, an increase of 3,913.98%. That is a compound annual growth rate of 19.11%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 87.71B |
| Intesa Sanpaolo | 85.90B |
| Enel SpA | 81.59B |
| Ferrari | 72.64B |
| Assicurazioni Generali | 45.34B |
| Eni S.p.A. | 40.33B |
| Leonardo S.p.a. | 26.64B |
| Stellantis | 24.51B |